Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-24-010676

CHIEF OPERATING OFFICER sold 4,875 shares at an average $18.60 ($90,687)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Patel Anish · CHIEF OPERATING OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-04-08 Sale : show line 1 in the form 10b5-1 −4,331 $18.50 $80,134 3,141 D
2024-04-08 Sale : show line 2 in the form 10b5-1 −544 $19.40 $10,552 2,597 D
Open-market sales · 4,875 sh · avg $18.60 · $90,687
Loading xslF345X05/form4-04112024_120405.xml…